Andreas Hillarp
1 – 119 of 119
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
(
- Contribution to journal › Article
-
Mark
Elevated FVIII levels in hereditary hemorrhagic telangiectasia : Implications for clinical management
2023) In Laryngoscope Investigative Otolaryngology(
- Contribution to journal › Article
- 2022
-
Mark
Haemoglobin and red blood cell reference intervals during infancy
(
- Contribution to journal › Article
-
Mark
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex
(
- Contribution to journal › Article
-
Mark
Rutinmässig screening med APTT är inte indicerad före operation
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Serum amyloid P component : A new biomarker for low sperm concentration?
(
- Contribution to journal › Article
-
Mark
Soluble Transferrin Receptor during infancy and reference intervals for the Roche Cobas platform
(
- Contribution to journal › Article
-
Mark
Presentation and formatting of laboratory results : a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group "postanalytical phase" (WG-POST)
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays
(
- Contribution to journal › Article
- 2018
-
Mark
Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
(
- Contribution to journal › Article
- 2017
-
Mark
Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits : A two-centre study
(
- Contribution to journal › Article
-
Mark
Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD – A longitudinal study
(
- Contribution to journal › Article
-
Mark
Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments
(
- Contribution to journal › Article
- 2016
-
Mark
Intraoperative Hydroxyethyl Starch and its Effects on Different Fibrinogen Measurements.
(
- Contribution to journal › Article
-
Mark
Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits : A two-center study
(
- Contribution to journal › Article
-
Mark
Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact : A case report
(
- Contribution to journal › Article
- 2015
-
Mark
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.
(
- Contribution to journal › Article
-
Mark
Perioperative changes in PIVKA-II
(
- Contribution to journal › Article
-
Mark
Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.
(
- Contribution to journal › Article
-
Mark
Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotension.
(
- Contribution to journal › Article
-
Mark
One-stage vs. chromogenic assays in haemophilia A
(
- Contribution to journal › Scientific review
-
Mark
Comparison of automated von Willebrand factor activity assays.
2015) In Thrombosis Research(
- Contribution to journal › Article
-
Mark
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
(
- Contribution to journal › Article
- 2014
-
Mark
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.
(
- Contribution to journal › Article
-
Mark
Laboratory aspects of von Willebrand disease : test repertoire and options for activity assays and genetic analysis
(
- Contribution to journal › Scientific review
-
Mark
Clinically relevant non-neutralizing anti-FVIII antibodies in a hemophiliac
(
- Contribution to journal › Letter
-
Mark
Assay discrepancy in mild haemophilia A
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Long-term anti-FVIII antibody response in Bethesda-negative haemophilia A patients receiving continuous replacement therapy.
(
- Contribution to journal › Article
-
Mark
Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa : A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis
(
- Contribution to journal › Article
- 2012
-
Mark
Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency
(
- Contribution to journal › Article
-
Mark
Prospective Longitudinal Study of Thromboelastography and Standard Hemostatic Laboratory Tests in Healthy Women During Normal Pregnancy
(
- Contribution to journal › Article
-
Mark
Lupus anticoagulants in two children-bleeding due to nonphospholipid-dependent antiprothrombin antibodies.
(
- Contribution to journal › Article
-
Mark
Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders
(
- Contribution to journal › Article
-
Mark
Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.
2012) In Haemophilia(
- Contribution to journal › Article
- 2011
-
Mark
Determination of serum amyloid P component in seminal plasma and correlations with serum hormone levels in young, healthy men.
(
- Contribution to journal › Article
-
Mark
Nordic Haemophilia Council's Practical Guidelines on Diagnosis and Management of von Willebrand Disease
(
- Contribution to journal › Article
-
Mark
Practical Viewpoints on the Diagnosis and Management of Heparin-Induced Thrombocytopenia
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
(
- Contribution to journal › Article
-
Mark
Ovanliga ärftliga former av blödarsjuka. Blödningssymtom, familjehistoria och laboratorieanalyser ger diagnosen.
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
(
- Contribution to journal › Article
- 2010
-
Mark
Considerations in the laboratory assessment of haemostasis
(
- Contribution to journal › Scientific review
-
Mark
Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay (VWF:RCo) using a novel automated assay protocol
(
- Contribution to journal › Published meeting abstract
-
Mark
Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study
(
- Contribution to journal › Article
-
Mark
Comparison of several automated VWF:RCo assays for monitoring of patients treated with VWF/FVIII concentrates: improved performance with a new modified method
(
- Contribution to journal › Published meeting abstract
-
Mark
Use and limitations of APTT as a screening test for mild bleeding disorders
(
- Contribution to journal › Published meeting abstract
-
Mark
Anti-prothrombin antibodies are associated with thrombosis in children.
(
- Contribution to journal › Article
-
Mark
Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.
(
- Contribution to journal › Article
-
Mark
Von Willebrands sjukdom--från biokemi till klinisk praxis.
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Improved automated VWF:RCo assay for VWF/FVIII concentrates and plasma samples by adjustment of assay reagents, composition and performance parameters
(
- Contribution to journal › Published meeting abstract
-
Mark
Minor stroke as singular manifestation of hereditary thrombotic thrombocytopenic purpura in a young man.
(
- Contribution to journal › Article
-
Mark
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
(
- Contribution to journal › Article
-
Mark
Trombocytopeni kan vara HIT. Heparinbehandling kan ge livshotande låga trombocytvärden
(
- Contribution to journal › Article
- 2008
-
Mark
The pentraxin serum amyloid P component is found in the male genital tract and attached to spermatozoa
(
- Contribution to journal › Article
-
Mark
VWF : RCo assays using automated systems for VWF/FVIII concentrates require adjustment of assay reagents, composition and performance parameters
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.116-116(
- Contribution to journal › Published meeting abstract
-
Mark
Natural anticoagulation and endothelial markers in association with allogeneic stem cell transplantation and graft-versus-host disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes
(
- Contribution to journal › Article
-
Mark
Ny markør ved trombotisk trombocytopenisk purpura
(
- Contribution to journal › Scientific review
-
Mark
Blödningstidsbestämning har spelat ut sin roll. Otillförlitlig metod som inte längre bör användas i rutinsjukvården
(
- Contribution to journal › Scientific review
-
Mark
ADAMTS13 - aktör och markör vid trombotisk mikroangiopati
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Calibration services in the frame of accredited coagulation EQA schemes - Meeting the IVD directive
(
- Contribution to journal › Article
-
Mark
Influence of endotoxin challenge on protein S and C4b-binding protein in healthy subjects
(
- Contribution to journal › Letter
-
Mark
Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity.
(
- Contribution to journal › Article
- 2005
-
Mark
Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee.
(
- Contribution to journal › Article
-
Mark
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal
(
- Contribution to journal › Letter
-
Mark
Large deletions of the PROS1 gene in a large fraction of mutationnegative patients with protein S deficiency
(
- Contribution to journal › Article
-
Mark
Molecular coagulation and thrombophilia.
2005) p.158-158(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2004
-
Mark
Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1.
(
- Contribution to journal › Article
-
Mark
Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
(
- Contribution to journal › Article
-
Mark
Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults.
(
- Contribution to journal › Article
-
Mark
Genetic variation in the human thrombomodulin promoter locus and prognosis after acute coronary syndrome.
(
- Contribution to journal › Article
-
Mark
A comparative in vitro evaluation of six von Willebrand factor concentrates.
(
- Contribution to journal › Article
-
Mark
Resistens mot acetylsalicylsyra - klinisk diagnos utan klarlagd mekanism
(
- Contribution to journal › Article
-
Mark
Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.
(
- Contribution to journal › Article
-
Mark
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
(
- Contribution to journal › Article
- 2003
-
Mark
Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system
(
- Contribution to journal › Letter
-
Mark
Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H.
(
- Contribution to journal › Article
-
Mark
Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity.
(
- Contribution to journal › Letter
-
Mark
Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke.
(
- Contribution to journal › Article
-
Mark
Increased sensitivity to ADP-aggregation in aspirin treated patients with recurrent ischemic stroke?
(
- Contribution to journal › Article
-
Mark
Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.
(
- Contribution to journal › Article
-
Mark
Diagnosing protein S deficiency: analytical considerations.
(
- Contribution to journal › Article
- 2002
-
Mark
Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein.
(
- Contribution to journal › Article
-
Mark
Mer samstämmiga laboratorieresultat efter övergången till INR. Skillnaderna mellan sjukhus- och primärvårdslaboratorier utjämnade
(
- Contribution to journal › Article
- 2001
-
Mark
Analytical considerations for free protein S assays in protein S deficiency
(
- Contribution to journal › Article
-
Mark
Ny in vitro-analys prövad: Blödningstid fortfarande bästa metod för test av den primära hemostasen
(
- Contribution to journal › Article
-
Mark
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism : Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls
(
- Contribution to journal › Article
- 2000
-
Mark
Använd hela "analyspaketet" vid utredning av trombospatienten! Och glöm inte släktingarna ...
(
- Contribution to journal › Article
-
Mark
Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion
(
- Contribution to journal › Article
- 1999
-
Mark
Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin
(
- Contribution to journal › Article
-
Mark
Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Thrombophilia as a multigenic disease
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion
(
- Contribution to journal › Article
-
Mark
The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion
(
- Contribution to journal › Article
-
Mark
Samordnad svensk övergång rekommenderas under 1999. Protrombinkomplexmätning bör anges som en kvot, inte i procent
(
- Contribution to journal › Article
- 1998
-
Mark
A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen
(
- Contribution to journal › Article
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
(
- Contribution to journal › Letter
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
(
- Contribution to journal › Letter
-
Mark
Geographic distribution of the 20210 G to A prothrombin variant
(
- Contribution to journal › Article
- 1997
-
Mark
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Activated protein C resistance caused by a common factor V mutation has a single origin
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance : Clinical implications
(
- Contribution to journal › Scientific review
-
Mark
The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function
(
- Contribution to journal › Article
-
Mark
Molecular cloning of rat C4b binding protein alpha- and beta-chains : structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins
(
- Contribution to journal › Article
- 1996
-
Mark
Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis
(
- Contribution to journal › Scientific review
-
Mark
Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance as a basis for venous thrombosis.
(
- Contribution to journal › Article
- 1995
-
Mark
Activated protein C resistance : from phenotype to genotype and clinical practice
(
- Contribution to journal › Article
- 1994
-
Mark
Bovine C4b binding protein. Molecular cloning of the alpha- and beta-chains provides structural background for lack of complex formation with protein S
(
- Contribution to journal › Article
- 1993
-
Mark
The human C4b-binding protein beta-chain gene
(
- Contribution to journal › Article
- 1991
-
Mark
Molecular analysis of the beta-chain of human C4b-binding protein
(
- Contribution to journal › Scientific review
- 1990
-
Mark
Assembly of protein S and C4b-binding protein on membranes
(
- Contribution to journal › Article
-
Mark
Genes for C4b-binding protein alpha- and beta-chains (C4BPA and C4BPB) are located on chromosome 1, band 1q32, in humans and on chromosome 13 in rats
(
- Contribution to journal › Article
-
Mark
Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement
1990) In Proceedings of the National Academy of Sciences of the United States of America 87(12). p.32-4529(
- Contribution to journal › Article
-
Mark
Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein : sequence homology with the alpha chain
1990) In Proceedings of the National Academy of Sciences of the United States of America 87(3). p.1183-1187(
- Contribution to journal › Article
- 1989
-
Mark
Protein S binding in relation to the subunit composition of human C4b-binding protein
(
- Contribution to journal › Article
- 1988
-
Mark
Novel subunit in C4b-binding protein required for protein S binding
(
- Contribution to journal › Article
- 1987
-
Mark
The protein S-binding site localized to the central core of C4b-binding protein
(
- Contribution to journal › Article